The SOURCE-Registry (largest consecutive cohort treated using Edwards SAPIEN bioprosthesis in Europe) demonstrate excellent the mid-term results (GREATER-THAN OR EQUAL TO30 days-2 years) of transapical aortic valve implantation in elderly patients with aortal stenosis and severe co-morbidities